Home > Insider Trading > Filing (0001209191-11-042502)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1492426	Horizon Pharma Inc.	HZNP	Pharmaceutical Preparations (2834)	272179987

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1369942	Peter Johann	C/O Horizon Pharma, Inc. 1033 Skokie Blvd., Suite 355 Northridge IL 60062		Yes	No	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-08-02	401,927	$0.00	401,927	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	555,956	$0.00	957,883	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	44,364	$0.00	1,002,247	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	61,366	$0.00	1,063,613	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	89,652	$9.00	1,153,265	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	124,007	$9.00	1,277,272	No	4	C	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	81,671	$9.00	1,358,943	No	4	P	Indirect	See FN
Common Stock	Acquisiton	2011-08-02	112,968	$9.00	1,471,911	No	4	P	Indirect	See FN

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	C	Indirect	See FN
No	4	P	Indirect	See FN
No	4	P	Indirect	See FN

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Convertible Preferred Stock	Disposition	2011-08-02	401,927	$0.00	401,927	$0.00
Common Stock	Series A Convertible Preferred Stock	Disposition	2011-08-02	555,956	$0.00	555,956	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2011-08-02	44,364	$0.00	44,364	$0.00
Common Stock	Series B Convertible Preferred Stock	Disposition	2011-08-02	61,366	$0.00	61,366	$0.00
Common Stock	Convertible Promissory Notes	Disposition	2011-08-02	0	$0.00	89,652	$9.00
Common Stock	Convertible Promissory Notes	Disposition	2011-08-02	0	$0.00	124,007	$9.00

Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect
No	4	C	Indirect

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,523,642	Indirect	See FN
Common Stock	1,595,198	Indirect	See FN

Footnotes

Automatic conversion, in connection with the Issuer's initial public offering, of preferred stock into shares of common stock. Every 2.374 shares of preferred stock converted into one share of common stock upon the closing of the Issuer's initial public offering.
The securities are held of record by NGN Biomed Opportunity I GmbH & Co. Beteiligungs KG ("NGN Biomed").
The reporting person is a Managing General Partner of NGN Capital LLC, which is the general partner of the general partner of NGN BioMed and is the managing limited partner of NGN BioMed GMBH. The Reporting Person disclaims beneficial ownership with respect to these securities, except to the extent of his pecuniary interest therein.
The securities are held of record by NGN Biomed Opportunity I, L.P. ("NGN Biomed").
Represents shares acquired upon conversion, in connection with the Issuer's initial public offering, of convertible promissory notes.
These securities are preferred stock of the Issuer and did not have an expiration date. Prior to the Issuer's initial public offering of common stock, the securities were convertible at any time at the election of the holder. The securities automatically converted into shares of common stock upon the closing of the issuer's initial public offering of common stock.
Principal and accrued interest converted upon the Issuer's initial public offering of common stock, into shares of common stock.